Skip to ContentSkip to Navigation

Stephen J. Kim, M.D.

Education

Stephen J. Kim, M.D.
Education
M.D., John Hopkins University
B.S., Duke University
Postgraduate Training
Internship
Internal Medicine, Mercy Medical Center, Baltimore, MD
Residency
Ophthalmology, Wilmer Eye Institute, John Hopkins Hospital, Baltimore, MD
Fellowship
Vitreoretinal Diseases and Surgery, Emory Eye Center,
 Atlanta, GA
Ocular Immunology and Uveitis, Wilmer Eye Institute, Johns Hopkins Hospital, Baltimore, MD
Board Certification
American Board of Ophthalmology
Professional Affiliations
Macula Society
American Society of Retina Specialists
Nashville Academy of Ophthalmology
Association for Research in Vision & Ophthalmology
American Academy of Ophthalmology
Phi Beta Kappa
American Medical Association
Honors and Awards
Guide to America's Top Ophthalmologist 2011
Marquis Who's Who in America 2012 (66th Edition)
Excellence in Clinical Instruction, Vanderbilt University, 2010, 2011
Ronald G. Michels Fellowship Foundation, 2007
Margherio Award, The Retina Society, Boston, MA, 2007
Fellowship Research Award, Emory University, 2007
Heed Ophthalmic Foundation, 2007
Fellowship Teaching Award, Wilmer Eye Institute, 2006
Areas of Clinical Expertise
Diabetic Retinopathy
Retinal Vascular Disorders
Age-Related Macular Degeneration
Ocular Infection and Inflammation
Research Interests
Post-Surgical Cystoid Macular Edema
Posterior Segment Uveitis
Diabetic Macular Edema
Age-Related Macular Degeneration
Ongoing Clinical Trials
Antibiotic Resistance of Conjunctiva and Nasopharynx Evaluation (ARCaNE) Study
Intravitreal Ketorolac for Chronic Inflammation and Retinal Edema (INCITE) Study
Prospective Retinal and Optic Nerve Vitrectomy Evaluation (PROVE) Study
Prospective Surveillance of Patients with Endophthalmitis for Multiantibiotic Resistance (PROSPER) Study
Background
Dr. Kim is a nationally recognized expert in the medical and surgical management of retinal disease and uveitis, including the use and monitoring of systemic immunosuppression. Dr. Kim also actively engages in basic, translational, and clinical research. Dr. Kim is a frequent invited lecturer at major ophthalmic meetings and has authored or co-authored over 80 journal articles and published abstracts.  He is a leading authority on nonsteroidal anti-inflammatory drugs for the treatment of ocular inflammation and on the emergence of antibiotic resistance.Education

  • M.D., John Hopkins University
  • B.S., Duke University

Postgraduate Training

Internship

  • Internal Medicine, Mercy Medical Center, Baltimore, MD

Residency

  • Ophthalmology, Wilmer Eye Institute, John Hopkins Hospital, Baltimore, MD

Fellowship

  • Vitreoretinal Diseases and Surgery, Emory Eye Center, Atlanta, GA
  • Ocular Immunology and Uveitis, Wilmer Eye Institute, Johns Hopkins Hospital, Baltimore, MD

Board Certification

  • American Board of Ophthalmology

Professional Affiliations

  • Macula Society
  • American Society of Retina Specialists
  • Nashville Academy of Ophthalmology
  • Association for Research in Vision & Ophthalmology
  • American Academy of Ophthalmology
  • Phi Beta Kappa
  • American Medical Association

Honors and Awards

  • Guide to America's Top Ophthalmologist 2011
  • Marquis Who's Who in America 2012 (66th Edition)
  • Excellence in Clinical Instruction, Vanderbilt University, 2010, 2011
  • Ronald G. Michels Fellowship Foundation, 2007
  • Margherio Award, The Retina Society, Boston, MA, 2007
  • Fellowship Research Award, Emory University, 2007
  • Heed Ophthalmic Foundation, 2007
  • Fellowship Teaching Award, Wilmer Eye Institute, 2006

Areas of Clinical Expertise

  • Diabetic Retinopathy
  • Retinal Vascular Disorders
  • Age-Related Macular Degeneration
  • Ocular Infection and Inflammation

Research Interests

  • Post-Surgical Cystoid Macular Edema
  • Posterior Segment Uveitis
  • Diabetic Macular Edema
  • Age-Related Macular Degeneration

Ongoing Clinical Trials

  • Antibiotic Resistance of Conjunctiva and Nasopharynx Evaluation (ARCaNE) Study
  • Intravitreal Ketorolac for Chronic Inflammation and Retinal Edema (INCITE) Study
  • Prospective Retinal and Optic Nerve Vitrectomy Evaluation (PROVE) Study
  • Prospective Surveillance of Patients with Endophthalmitis for Multiantibiotic Resistance (PROSPER) Study

Background

Dr. Kim is a nationally recognized expert in the medical and surgical management of retinal disease and uveitis, including the use and monitoring of systemic immunosuppression. Dr. Kim also actively engages in basic, translational, and clinical research. Dr. Kim is a frequent invited lecturer at major ophthalmic meetings and has authored or co-authored over 80 journal articles and published abstracts.  He is a leading authority on nonsteroidal anti-inflammatory drugs for the treatment of ocular inflammation and on the emergence of antibiotic resistance.

For questions or problems concerning this page, please submit a help ticket.

twitter facebook flickr youtube

Vanderbilt School of Medicine | 215 Light Hall | Nashville, TN 37232
Vanderbilt University is committed to principles of equal opportunity and affirmative action.
Copyright © 2014, Vanderbilt University School of Medicine.